In this blog I want to highlight some critical updates from the General Pharmaceutical Council (GPhC) that every pharmacy professional—whether you’re a pharmacist, technician, or pharmacy owner—should be aware of. These issues have prompted serious regulatory concerns and demand thoughtful consideration and action where appropriate.
Risk Assessments are a regulatory requirement in medicines wholesaling but have you considered that they could also be very useful in pharmacy practice?
The MHRA have updated their Blue Guide on Advertising and Promoting Medicines. The update is to Appendix 4 with new Best Practice guidance on the sale of medicines for pain relief.
Are you advertising Prescription Only Medicines (POM) utilising a prescribing service? Do you know it is illegal to advertise a POM?
The GPhC has released new standards for the Chief Pharmacist in January 2025. Have you read them? This blog summarises the standards provided. Find them in their entirety here.
Now we have started 2025, this blog highlights the common trends identified from GPhC inspections carried out in 2024.
